375 related articles for article (PubMed ID: 32302946)
1. Early diagnosis of Alzheimer's disease: the role of biomarkers including advanced EEG signal analysis. Report from the IFCN-sponsored panel of experts.
Rossini PM; Di Iorio R; Vecchio F; Anfossi M; Babiloni C; Bozzali M; Bruni AC; Cappa SF; Escudero J; Fraga FJ; Giannakopoulos P; Guntekin B; Logroscino G; Marra C; Miraglia F; Panza F; Tecchio F; Pascual-Leone A; Dubois B
Clin Neurophysiol; 2020 Jun; 131(6):1287-1310. PubMed ID: 32302946
[TBL] [Abstract][Full Text] [Related]
2. Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study'.
Galluzzi S; Marizzoni M; Babiloni C; Albani D; Antelmi L; Bagnoli C; Bartres-Faz D; Cordone S; Didic M; Farotti L; Fiedler U; Forloni G; Girtler N; Hensch T; Jovicich J; Leeuwis A; Marra C; Molinuevo JL; Nobili F; Pariente J; Parnetti L; Payoux P; Del Percio C; Ranjeva JP; Rolandi E; Rossini PM; Schönknecht P; Soricelli A; Tsolaki M; Visser PJ; Wiltfang J; Richardson JC; Bordet R; Blin O; Frisoni GB;
J Intern Med; 2016 Jun; 279(6):576-91. PubMed ID: 26940242
[TBL] [Abstract][Full Text] [Related]
3. Classification of Alzheimer's Disease with Respect to Physiological Aging with Innovative EEG Biomarkers in a Machine Learning Implementation.
Vecchio F; Miraglia F; Alù F; Menna M; Judica E; Cotelli M; Rossini PM
J Alzheimers Dis; 2020; 75(4):1253-1261. PubMed ID: 32417784
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers in Alzheimer's disease with a special emphasis on event-related oscillatory responses.
Yener GG; Başar E
Suppl Clin Neurophysiol; 2013; 62():237-73. PubMed ID: 24053044
[TBL] [Abstract][Full Text] [Related]
5. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
[TBL] [Abstract][Full Text] [Related]
6. Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage.
Drago V; Babiloni C; Bartrés-Faz D; Caroli A; Bosch B; Hensch T; Didic M; Klafki HW; Pievani M; Jovicich J; Venturi L; Spitzer P; Vecchio F; Schoenknecht P; Wiltfang J; Redolfi A; Forloni G; Blin O; Irving E; Davis C; Hårdemark HG; Frisoni GB
J Alzheimers Dis; 2011; 26 Suppl 3():159-99. PubMed ID: 21971460
[TBL] [Abstract][Full Text] [Related]
7. Studying the Alzheimer's disease continuum using EEG and fMRI in single-modality and multi-modality settings.
Li J; Li X; Chen F; Li W; Chen J; Zhang B
Rev Neurosci; 2024 Jun; 35(4):373-386. PubMed ID: 38157429
[TBL] [Abstract][Full Text] [Related]
8. T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.
Haris M; Yadav SK; Rizwan A; Singh A; Cai K; Kaura D; Wang E; Davatzikos C; Trojanowski JQ; Melhem ER; Marincola FM; Borthakur A
Neuroimage Clin; 2015; 7():598-604. PubMed ID: 25844314
[TBL] [Abstract][Full Text] [Related]
9. Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.
Ruan Q; D'Onofrio G; Sancarlo D; Bao Z; Greco A; Yu Z
BMC Geriatr; 2016 May; 16():104. PubMed ID: 27184250
[TBL] [Abstract][Full Text] [Related]
10. [Volumetric brain changes and quantitative EEG in normal aging and Alzheimer's dementia].
Förstl H; Besthorn C; Sattel H; Zerfass R; Geiger-Kabisch C; Schreiter-Gasser U; Hentschel F
Nervenarzt; 1996 Jan; 67(1):53-61. PubMed ID: 8676989
[TBL] [Abstract][Full Text] [Related]
11. Cortical sources of resting state EEG rhythms are sensitive to the progression of early stage Alzheimer's disease.
Babiloni C; Lizio R; Del Percio C; Marzano N; Soricelli A; Salvatore E; Ferri R; Cosentino FI; Tedeschi G; Montella P; Marino S; De Salvo S; Rodriguez G; Nobili F; Vernieri F; Ursini F; Mundi C; Richardson JC; Frisoni GB; Rossini PM
J Alzheimers Dis; 2013; 34(4):1015-35. PubMed ID: 23340039
[TBL] [Abstract][Full Text] [Related]
12. Cognitive MMN and P300 in mild cognitive impairment and Alzheimer's disease: A high density EEG-3D vector field tomography approach.
Papadaniil CD; Kosmidou VE; Tsolaki A; Tsolaki M; Kompatsiaris IY; Hadjileontiadis LJ
Brain Res; 2016 Oct; 1648(Pt A):425-433. PubMed ID: 27485659
[TBL] [Abstract][Full Text] [Related]
13. Quantitative EEG power and synchronization correlate with Alzheimer's disease CSF biomarkers.
Smailovic U; Koenig T; Kåreholt I; Andersson T; Kramberger MG; Winblad B; Jelic V
Neurobiol Aging; 2018 Mar; 63():88-95. PubMed ID: 29245058
[TBL] [Abstract][Full Text] [Related]
14. The Italian INTERCEPTOR Project: From the Early Identification of Patients Eligible for Prescription of Antidementia Drugs to a Nationwide Organizational Model for Early Alzheimer's Disease Diagnosis.
Rossini PM; Cappa SF; Lattanzio F; Perani D; Spadin P; Tagliavini F; Vanacore N
J Alzheimers Dis; 2019; 72(2):373-388. PubMed ID: 31594234
[TBL] [Abstract][Full Text] [Related]
15. EEG time signature in Alzheimer´s disease: Functional brain networks falling apart.
Smailovic U; Koenig T; Laukka EJ; Kalpouzos G; Andersson T; Winblad B; Jelic V
Neuroimage Clin; 2019; 24():102046. PubMed ID: 31795039
[TBL] [Abstract][Full Text] [Related]
16. A Review of Automated Techniques for Assisting the Early Detection of Alzheimer's Disease with a Focus on EEG.
Perez-Valero E; Lopez-Gordo MA; Morillas C; Pelayo F; Vaquero-Blasco MA
J Alzheimers Dis; 2021; 80(4):1363-1376. PubMed ID: 33682717
[TBL] [Abstract][Full Text] [Related]
17. Two-Year Longitudinal Monitoring of Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease Using Topographical Biomarkers Derived from Functional Magnetic Resonance Imaging and Electroencephalographic Activity.
Jovicich J; Babiloni C; Ferrari C; Marizzoni M; Moretti DV; Del Percio C; Lizio R; Lopez S; Galluzzi S; Albani D; Cavaliere L; Minati L; Didic M; Fiedler U; Forloni G; Hensch T; Molinuevo JL; Bartrés Faz D; Nobili F; Orlandi D; Parnetti L; Farotti L; Costa C; Payoux P; Rossini PM; Marra C; Schönknecht P; Soricelli A; Noce G; Salvatore M; Tsolaki M; Visser PJ; Richardson JC; Wiltfang J; Bordet R; Blin O; Frisoniand GB;
J Alzheimers Dis; 2019; 69(1):15-35. PubMed ID: 30400088
[TBL] [Abstract][Full Text] [Related]
18. CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease.
Lista S; Garaci FG; Ewers M; Teipel S; Zetterberg H; Blennow K; Hampel H
Alzheimers Dement; 2014 May; 10(3):381-92. PubMed ID: 23850330
[TBL] [Abstract][Full Text] [Related]
19. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
